- Home
- ANEB vs ACCS Comparison
ANEB vs ACCS Comparison
Compare ANEB & ACCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- ACCS
- Stock Information
- Founded
- ANEB 2020
- ACCS 1988
- Country
- ANEB United States
- ACCS United States
- Employees
- ANEB N/A
- ACCS N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- ACCS Publishing
- Sector
- ANEB Health Care
- ACCS Consumer Discretionary
- Exchange
- ANEB Nasdaq
- ACCS Nasdaq
- Market Cap
- ANEB 39.0M
- ACCS 44.2M
- IPO Year
- ANEB 2021
- ACCS N/A
- Fundamental
- Price
- ANEB $2.85
- ACCS $12.20
- Analyst Decision
- ANEB Buy
- ACCS Strong Buy
- Analyst Count
- ANEB 2
- ACCS 1
- Target Price
- ANEB $8.00
- ACCS $15.00
- AVG Volume (30 Days)
- ANEB 1.1M
- ACCS 14.4K
- Earning Date
- ANEB 09-24-2025
- ACCS 08-11-2025
- Dividend Yield
- ANEB N/A
- ACCS N/A
- EPS Growth
- ANEB N/A
- ACCS N/A
- EPS
- ANEB N/A
- ACCS N/A
- Revenue
- ANEB N/A
- ACCS $22,961,000.00
- Revenue This Year
- ANEB N/A
- ACCS $3.05
- Revenue Next Year
- ANEB N/A
- ACCS $15.47
- P/E Ratio
- ANEB N/A
- ACCS N/A
- Revenue Growth
- ANEB N/A
- ACCS 6.92
- 52 Week Low
- ANEB $0.80
- ACCS $7.79
- 52 Week High
- ANEB $3.42
- ACCS $13.35
- Technical
- Relative Strength Index (RSI)
- ANEB 66.43
- ACCS N/A
- Support Level
- ANEB $1.53
- ACCS N/A
- Resistance Level
- ANEB $3.42
- ACCS N/A
- Average True Range (ATR)
- ANEB 0.20
- ACCS 0.00
- MACD
- ANEB 0.05
- ACCS 0.00
- Stochastic Oscillator
- ANEB 69.84
- ACCS 0.00
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
About ACCS ACCESS Newswire Inc. Common Stock
ACCESS Newswire Inc is a Public Relations (PR) and Investor Relations (IR) solutions provider. The group focuses on innovation, customer service, and value-driven offerings, ACCESS Newswire empowers brands.